Cagrilintide is a newer long-acting amylin analogue - in a phase 2 trial, once weekly cagrilintide resulted in a dose-dependent WL between 6 and 10.8% compared to 9% with liraglutide 3 mg and 3% with placebo [87]
View details Recovery & Structural BPC/TB5 Blend The BPC-157 + TB-500 blend combines two of the most researched structural and recovery peptides into a single research formulation, studied across structural, vascular, and epithelial models
39 Research indicates that L-GSH shows promise as an effective adjunctive treatment in patients with HIV or TB, and studies have reported L-GSH may also play a potential role in the treatment of other human pathologies that cause a decrease n the levels of GSH, a redox imbalance, and increased levels of TGF-
Biological Analysis of Drug Immunogenicity of GLP-1 Analogs Like other biologics, patients receiving GLP-1 analog drugs may develop corresponding anti-drug antibodies (ADAs) and neutralizing antibodies (NAbs) in their bodies
Circulating sex hormones and risk of uterine fibroids: Study of Women's Health Across the Nation (SWAN)